Search

New MSK research investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their 90s who underwent lung cancer surgery had positive outcomes; shares lessons on the responsible governance of artificial intelligence in oncology; studies AI-assisted biomarker assessment in lung cancer; and demonstrates a cancer-trained large language model has strong predictive value.

… Tuesday, July 15, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their 90s who underwent lung cancer surgery had positive outcomes; shares lessons on

Early-onset colorectal cancer (CRC) is likely clinically and genomically indistinguishable from average-onset cancer, according to a recent study published in the Journal of the National Cancer Institute by MSK investigators.

… Monday, September 13, 2021 Early-onset colorectal cancer (CRC) is likely clinically and genomically indistinguishable from average-onset cancer, according to a recent study published in the Journal of the National Cancer Institute by MSK investigators.The findings suggest that aggressive treatment for

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Tuesday, June 21, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Alban Ordureau Selected into the 2022 Class of Pew Scholars in Biomedical Sciences Alban Ordureau, PhD Alban Ordureau, PhD , has been selected into the 2022 class of Pew Scholars in Biomedical

Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.

… Tuesday, December 1, 2009 Summary Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors. Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be

People with prostate cancer can benefit from exercise in more ways than they might expect.

… Thursday, September 24, 2020 Summary Treatments for prostate cancer can cause side effects such as loss of muscle mass and fatigue.  Finding the time and energy to exercise is difficult for many people. For men diagnosed with prostate cancer, it can be especially challenging because treatments often

Learn how Dr. Chrysothemis Brown is shedding light on new types of immune cells and their role in cancer and other diseases.

… Tuesday, November 7, 2023 When physician-scientist Chrysothemis Brown, MBBS, PhD , talks about the process of scientific discovery and the nuances of the immune system, the sincerity of her enthusiasm is unmistakable. “What I love about science is the freedom and creativity,” Dr. Brown says. “And if

In the largest-ever genetic analysis of people being treated with checkpoint inhibitors, Memorial Sloan Kettering researchers looked at patients who received several checkpoint inhibitors for a number of different cancers at many different hospitals. Researchers found that people who had a greater diversity and more variation in their human leukocyte antigen (HLA) genes responded much better to immunotherapy compared with those who had less diversity. For more information or to speak with an expert, contact Rebecca Williams at [email protected].

… Thursday, December 7, 2017 Bottom line: Patient-specific HLA genotype influences response to immune checkpoint inhibitors . Journal: “Patient HLA genotype influences cancer response to checkpoint blockade immunotherapy” appears in the December 7, 2017, issue of Science . Authors : The senior author was

Can turmeric fight cancer? Learn more from an MSK expert about what the science says.

… Monday, April 13, 2026 Turmeric, the brilliant yellow spice native to southeast Asia, has long been prized in India and elsewhere for its apparent healing powers. For more than 5,000 years, people have used it to treat a variety of ailments, including skin disorders and digestive issues. Contemporary

The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), made possible by a generous $40 million gift from Henry R. Kravis to honor the visionary leadership of his wife, Marie-Josée Kravis, will establish a strategic research infrastructure that will seamlessly unite MSK scientists and physicians to further accelerate immunotherapy treatments for people with cancer.

… Monday, May 22, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the creation of The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), a hub for immunotherapy research that will elevate, centralize, and prioritize the full spectrum of immuno-oncology research across the institution

Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.

… Tuesday, March 31, 2015 Summary Cell therapies, a promising new type of cancer treatment, aim to boost the immune system by giving immune cells the information they need to better recognize tumor cells as foreign and attack them. These therapies are being used to treat a few types of cancer, with more